News

GEN Article: Supercharge Antibody Discovery Workflows with High-Throughput SPR

Read More

PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization

Read More

Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors

Read More

Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay

Read More

GEN Article: Eliminating Bottlenecks in mAb Drug Discovery

Twist Biopharma screens massive antibody libraries with the Carterra LSA to discover therapeutic antibodies in just weeks.

Read More

Podcast: Tim Germann our Chief Commercial Officer Discusses how Carterra has Become an Innovator and Driving Force in Therapeutic Antibody Discovery

Listen to Podcast

Nature Article: Speeding Antibody Screening for Drug Development

Advanced screening technology can dramatically accelerate the hunt for effective treatments for cancer, COVID-19 and more.

Read More

Video: Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic

Watch Video

Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)

Read More

Biocompare Article on How Epitope Binning Streamlines Discovery and Exploits Diversity

Epitope binning screens and characterizes antibodies in one step. Studying kinetics, affinity, and epitope relationships in high throughput allows characterization of antibody libraries generated against a specific antigen through B cell cloning, phage display, or hybridoma technologies.

Read More